FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2011/10/002058 [Registered on: 12/10/2011] Trial Registered Retrospectively
Last Modified On: 22/09/2011
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Siddha 
Study Design  Single Arm Study 
Public Title of Study   Siddha Medicine for Uthiravadha Suronitham (Rheumatoid Arthiritis ) 
Scientific Title of Study   A PILOT STUDY TO EVALUATE THE THERAPEUTIC EFFICACY OF SIDDHA HERBO MINERAL FORMULATION RAJA LOGA NATHA RASA PARPAM INTERNAL and AATTHIRADHI THAILAM EXTERNAL IN UTHIRAVATHASURONITHAM RHEUMATOID ARTHRITIS 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Ramya 
Designation  Pg Scholar 
Affiliation  NATIONAL INSTITUTE OF SIDDHA 
Address  NO 5/55 THIRUVALLUVAR NAGAR 2 ND CROSS KRISHNAGIRI
NATIONAL INSTITUTE OF SIDDHA TAMBARAM SANATORIUM CHENNAI-47
Kancheepuram
TAMIL NADU
635001
India 
Phone  9894538563  
Fax  9104422381314  
Email  ramyabsms@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DrRSRamaswamy 
Designation  HEAD OF THE DEPARTMENT 
Affiliation  NATIONAL INSTITUTE OF SIDDHA 
Address  NATIONAL INSTITUTE OF SIDDHA TAMBARAM SANATORIUM CHENNAI-47
NATIONAL INSTITUTE OF SIDDHA TAMBARAM SANATORIUM CHENNAI-47
Kancheepuram
TAMIL NADU
6000047
India 
Phone  9444941489  
Fax  9104422381314  
Email  dr.rsramaswamy@gmail.com  
 
Details of Contact Person
Public Query
 
Name  DrRSRamaswamy 
Designation  HEAD OF THE DEPARTMENT 
Affiliation  NATIONAL INSTITUTE OF SIDDHA 
Address  NATIONAL INSTITUTE OF SIDDHA TAMBARAM SANATORIUM CHENNAI-47
NATIONAL INSTITUTE OF SIDDHA TAMBARAM SANATORIUM CHENNAI-47
Kancheepuram
TAMIL NADU
6000047
India 
Phone  9444941489  
Fax  9104422381314  
Email  dr.rsramaswamy@gmail.com  
 
Source of Monetary or Material Support  
NATIONAL INSTITUTE OF SIDDHA TAMBARAM SANATORIUM CHENNAI 47 
 
Primary Sponsor  
Name  NATIONAL INSTITUTE OF SIDDHA 
Address  NATIONAL INSTITUTE OF SIDDHA TAMBARAM SANATORIUM CHENNAI 47 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NATIONAL INSTITUTE OF SIDDHA  NATIONAL INSTITUTE OF SIDDHA TAMBARAM SANATORIUM CHENNAI 47 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DrSRamya  NATIONAL INSTITUTE OF SIDDHA  NATIONAL INSTITUTE OF SIDDHA TAMBARAM SANATORIUM CHENNAI 47
Kancheepuram
TAMIL NADU 
9894538563
9104422381314
ramyabsms@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional ethical committee, National Institute of Siddha, Chennai-47  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  Rhematoid Arthritis (Uthira Vatha Suronitham),  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  1.Raja loga natha rasa parpam(Internal) 2.Aathiradhi thailam (External)  1.250 mgs bid with pepper powder and cows ghee 2.2 drops in each nostrils (Nasiyam) and also external application 
Comparator Agent  Not applicable  Not applicable 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  • Symmetrical joint involvement
• Arthritis of 3 or more joints
• Rheumatoid factor positive or negative
• Morning stiffness.
• Swelling especially in the inter-phalangeal joint.
• Patients who are willing for admission and stay in IPD for 48 days or willing to attend OPD
 
 
ExclusionCriteria 
Details  • Hypertension and other Cardiac ailments
• Diabetes mellitus
• Narcotics
• Alcoholics and smokers.
• Pregnancy and lactation
• History of trauma
• Neurological disorder
• Tuberculosis
• Any other serious illness
• Psoriatic arthritis
• Gouty arthritis
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
The outcome is aimed at reducing the pain and restricted joint movements.
Pain is assessed by Universal pain assessment scale.
 
0th day and 49th day 
 
Secondary Outcome  
Outcome  TimePoints 
ESR,RA factor,CRP  0TH AND 49TH DAY 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   18/01/2011 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   No previous publication on the intervention 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary  

This study is a single arm trial to evaluate the efficacy of siddha herbo mineral formulation Raja Loga Natha Rasa Parpam - internal drug 250mgs twice a day with pepper powder and ghee along with Aathiradhi thailam - External drug also given as nasal drops (Nasiyam) in Rheumatoid arthiritis (Uthiravadha suronitham).The internal drug consists of rasam(purifiedmercury),Gandhagam(purified sulphur),Sangu(conch shell) and Palagarai(marine shell).The external drug consists of sesame oil,gadi(Vineger),Thayir thelivu( supernatent of curd),Adhimadhuram,Indhuppu,Inji,Chukku,Aanai thippili and Vaai vidangam.The internal drug is selected from the text Prana Rakshamirdha Sindhu and External drug is taken from the text Agasthiyar Vaidhya Chinthamani ( authenticated text books for siddha medicine).There has been no clinical trial carried out till today with the above mentioned drugs.Hence the investigator proposed this trial.

 
Close